Loading insider details...
Latest Form 4 (Jun 22, 2026): Grant/Award of 5,248 HROW shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | HARROW, INC. (HROW) | Grant/Award | 5,248 | n/a |
| May 19, 2026 | HARROW, INC. (HROW) | Purchase | 1,000 | $31.0K |
| Feb 10, 2026 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Disposition to Issuer | 10,075 | n/a |
| Jun 24, 2025 | HARROW, INC. (HROW) | Grant/Award | 7,339 | n/a |
| Jun 13, 2025 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 1,439 | n/a |
| Feb 5, 2025 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 8,636 | n/a |
| Jun 17, 2024 | HARROW, INC. (HROW) | Grant/Award | 8,347 | n/a |
| Mar 11, 2024 | Harpoon Therapeutics, Inc. (HARP) | Disposition to Issuer | 5,000 | n/a |
| Jan 30, 2024 | HARROW, INC. (HROW) | Grant/Award | 3,119 | n/a |
| May 19, 2022 | Evolus, Inc. (EOLS) | Sale | 16,189 | $225.4K |